Sensitivity of HPV tests on stained vs. unstained cervical smears

Acta Cytologica

Volumn 49, Issue 6, 2005, Pages 595-599

  De Lang, Anna ^a   Wilander, Erik ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cervical smears; Human papillomavirus; Sensitivity; Staining

Indexed keywords

HYDROCHLORIC ACID; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; DNA DAMAGE; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SQUAMOUS CELL CARCINOMA; STAINING; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CYTOLOGY; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES;

EID: 27944484823     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000326245     Document Type: Article

References (21)

1. Pisani P, Parkin DM, Bray F, Ferlay J: Estimates of the worldwide mortality of 25 cancers in 1990. Int J Cancer 1999;83:18-29
2. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N: Human papillomavirus is a necessary cause of cervical cancer worldwide. J Pathol 1999;189:12-19
3. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV: The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-265
4. Vizcaino AP, Moreno V, Bosch FX, Munoz N, Barros-Dios WM, Borras J, Parkin DM: International trends in incidence of cervical cancer: II. Squamous-cell carcinoma. Int J Cancer 2000;86:429-435
5. Pontén J, Adami HO, Bergstrom R, Dillner J, Friberg LG, Gustafsson L, Miller AB, Parkin DM, Sparen P, Trichopoulos D: Strategies for global control of cervical cancer. Int J Cancer 1995;60:1-26
6. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, Matchar DB: Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: A systematic review. Ann Intern Med 2000;132:810-819
7. Sasieni PD, Cuzick J, Lynch-Framery E: Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. Br J Cancer 1996;73:1001-1005
8. Ho GY, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, Basu J, Tachezy R, Lewis R, Romney S: Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995;87:1365-1371
9. Nobbenhuis MA, Walboomers JM, Heimerhorst TJ, Rozendaal L, Remmink AJ, Risse EK, van der Linden HC, Voorhorst FJ, Kenemans P, Meijer CJ: Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: A prospective study. Lancet 1999;354:20-25
10. Solomon D, Schiffman M, Tarone R: Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial. J Natl Cancer Inst 2001;93:293-299
11. Little J: Human papillomavirus testing: Effectiveness of testing for high risk HPV for triage of low grade abnormal smears is being assessed in TOMBOLA trial. BMJ 2001;323:109-000
12. Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, Koutsky LA: Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: Comparison of sensitivity, specificity and frequency of referral. JAMA 2002;288:1749-1757
13. Crabtree D, Unkraut A, Cozens D, Smith T, Lucas C, Pennington D, Chaney L, Nestok B, Robinson-Smith T, Yassin R: Role for HPV testing in ASCUS: A cytologic-histologic correlation. Diagn Cytopathol 2002;27:382-386
14. Ho L, Terry G, Londesborough P, Cuzick J, Lorenzato F, Singer A: Human papillomavirus DNA detection in the management of women with twice mildly abnormal cytological smears. J Med Virol 2003;69:118-121
15. McGoogan E, Seagar AL, Cubie HA: Detection of high-risk human papillomavirus nucleic acid in archival cervical smears. Acta Cytol 1998;42:1079-1083
16. Jacobs MV, Zielinski D, Meijer CJ, Pol RP, Voorhorst FJ, de Schipper FA, Runsink AP, Snijders PJ, Walboomers JM: A simplified and reliable HPV testing of archival Papanicolaou-stained cervical smears: Application to cervical smears from cancer patients starting with cytologically normal smears. Br J Cancer 2000;82:1421-1426
17. Ylitalo N, Josefsson A, Melbye M, Sorensen P, Frisch M, Andersen PK, Sparen P, Gustafsson M, Magnusson P, Ponten J, Gyllensten U, Adami HO: A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ. Cancer Res 2000;60:6027-6032
18. De Roda Husman A-M, Walboomers JMM, van den Brule AJC, Meijer CJLM, Snijders PJF: The use of the general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995;76:1057-1062
19. Hansson BG, Forslund O, Bjerre B, Lindholm K, Nordenfelt E: Human papillomavirus types in routine cytological screening and at colposcopic examinations. Eur J Obstet Gynecol Reprod Biol 1993;52:49-55
20. Jacobs MV, Walboomers JM, Snijders PJ, Voorhorst FJ, Verheijen RH, Fransen-Daalmeijer N, Meijer CJ: Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: The age-related patterns for high-risk and low-risk types. Int J Cancer 2000;87:221-22 7
21. Puranen M, Saarikoski S, Syrjanen K, Syrjanen S: Polymerase chain reaction amplification of human papillomavirus DNA from archival Papanicolaou-stained cervical smears. Acta Cytol 1996;40:391-395